Our client was planning the clinical evaluation of its lead product, an innovative dermal matrix for the treatment of challenging hard-to-heal wounds, and wished to understand the current competitor landscape.
Our client was planning the clinical evaluation of its lead product, an innovative dermal matrix that had been designed to treat challenging hard-to-heal wounds. It understood that wound care technologies are rapidly developing and wanted to ensure that its product remained competitive as it invested in clinical evaluation. It also wished to keep abreast of its competitor’s activities, including clinical trials underway, any potential disruptive products on the horizon, and M&A activity. Our medical device consultant assigned to this project had in-depth knowledge of the wound care space and was able to undertake a rapid scan of the competitor landscape to provide some reassurance as the company moved into this new phase of investment and development.
We are a specialist medical device consultancy consisting of industry experts with long and successful track records in commercialising medical device products. We have broad functional and sector experience, and would welcome an opportunity to discuss with you any challenge relating to creating sustainable value from medical technologies.
Munna Choudhury of Alacramed will be attending UK BIOTECH SUMMIT 2019, on
Mark Wickham of Alacramed will be attending Med-Tech Innovation Expo 2019 at
We understand the need for accurate, tailored health economic and budget impact
Alacramed Ltd, St Johns Innovation Centre, Cowley Road, Cambridge,
+44 (0) 1223 421885